Endava Stock Is a Buy. Even a Recession Won’t Stop It.

Software is in a slump, but people are in short supply. That’s the kind of environment that could be good for information-technology consultant Endava With recession concerns rising, corporate spendin...

GoodRx Stock Gives Back Gain as Analysts Fret Over Problem With Grocer

Text size GoodRx revoked its financial guidance in May and has yet to restore it. Courtesy GoodRx GoodRx  stock briefly soared as investors welcomed news that the provider of pharmacy discount cards h...

GoodRx stock rockets after earnings as company says snag with large grocer has been resolved

Shares of GoodRx Holdings Inc. were popping more than 30% in after-hours trading Monday after the company, which offers services for people looking to compare prescription drug prices, topped expectat...

Xerox CEO Visentin Has Died. What It Means for the Company.

Text size John Visentin. Courtesy Xerox Xerox Holdings shares are in the spotlight as investors respond to news that CEO and Vice Chairman John Visentin has died unexpectedly at age 59, a development ...

GoodRx Beat Quartely Estimates. Here’s Why the Stock Is Falling.

Text size GoodRx had a strong first quarter but effectively removed 2022 guidance. Piksel/Dreamstime News that a large grocer is no longer accepting GoodRx’s pharmacy discount cards has wrecked the st...

GoodRx stock tanks after company says it’s unlikely to achieve 2022 outlook amid issue with grocery chain

Shares of GoodRx Holdings Inc. sank in after-hours trading Monday after the company, which offers tools that help consumers compare drug prices, exceeded expectations with its March-quarter results bu...

GoodRx Stock Is Plunging to a Record Low. Earnings and Guidance Missed.

Text size GoodRx Holdings stock took a turn for the worse late Monday, after the prescription-drug-referral platform posted disappointing fourth-quarter results. GoodRX GoodRx Holdings stock took a tu...